Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-05-12-Speech-4-264-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110512.25.4-264-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"It is positive that a reduction in antibiotic use has been recorded, and the publication of guidelines on the prudent use of antibiotics in a number of Member States has contributed to this.
Any decision leading to the administration of antimicrobials, whether to humans or animals, should be carefully considered and take into account the potential threat of antimicrobial resistance (AMR). In fact, this resistance affects both humans and animals, and can be transmitted from human to animal and
. I am well aware that AMR in humans is often caused by inadequate doses of antibiotic medicines and incorrect treatments, but it can also be through the transmission, via animals, of pathogenic bacteria carrying AMR genes, with serious consequences for public and animal health.
We are therefore faced with a truly cross-cutting issue requiring a coordinated approach at EU level that must seek to ensure that antimicrobials can remain an effective tool for combating disease, in both people and animals, must encourage prudent and responsible usage, and must limit any recourse to them to cases where it is strictly necessary."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples